i3 Pharmaceuticals
FDA Approved Drugs

i3 Pharmaceuticals

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 6
  • Latest Approval Date Jan 26, 2026
  • Data Source FDA
  • First Approval Date Aug 17, 2023
Company Overview

Company

i3 Pharmaceuticals

Country

U.S.A

Email

Social Profiles

Company Snapshot

i3 Pharmaceuticals

200 Park Avenue Warminster, PA 18974

U.S.A

www.i3pharmaceuticals.com/ View on Map
FDA Approved Drug Records ( 6 records )
2023
05 Oct
RX Application: 216828

Drug Name

GUANFACINE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2023-10-05

216828 / 1

Active Ingredient

GUANFACINE HYDROCHLORIDE

Application Number

216828

Product Number

1

Dosage Form

-

Strength

EQ 1MG BASE

Approval Date

2023-10-05

Regulatory Status

RX

2023
05 Oct
RX Application: 216828

Drug Name

GUANFACINE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2023-10-05

216828 / 2

Active Ingredient

GUANFACINE HYDROCHLORIDE

Application Number

216828

Product Number

2

Dosage Form

-

Strength

EQ 2MG BASE

Approval Date

2023-10-05

Regulatory Status

RX

2023
17 Aug
RX Application: 217114

Drug Name

MARAVIROC

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2023-08-17

217114 / 1

Active Ingredient

MARAVIROC

Application Number

217114

Product Number

1

Dosage Form

-

Strength

150MG

Approval Date

2023-08-17

Regulatory Status

RX

2023
17 Aug
RX Application: 217114

Drug Name

MARAVIROC

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2023-08-17

217114 / 2

Active Ingredient

MARAVIROC

Application Number

217114

Product Number

2

Dosage Form

-

Strength

300MG

Approval Date

2023-08-17

Regulatory Status

RX

2023
28 Aug
RX Application: 216488

Drug Name

POSACONAZOLE

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2023-08-28

216488 / 1

Active Ingredient

POSACONAZOLE

Application Number

216488

Product Number

1

Dosage Form

-

Strength

100MG

Approval Date

2023-08-28

Regulatory Status

RX

2026
26 Jan
RX Application: 219702

Drug Name

TRANEXAMIC ACID

Product Number

1

Dosage Form

-

Strength

650MG

Approval Date

2026-01-26

219702 / 1

Active Ingredient

TRANEXAMIC ACID

Application Number

219702

Product Number

1

Dosage Form

-

Strength

650MG

Approval Date

2026-01-26

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    6 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
6 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

GUANFACINE HYDROCHLORIDE

Application Number

216828

Product Number

1

Active Ingredient

GUANFACINE HYDROCHLORIDE

Dosage Form

-

Strength

EQ 1MG BASE

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.